title: Safety of combining ticlopidine with nadroparin in the routine treatment of chronic hemodialysis patients.
authors.forename: A M
authors.initials: AM
authors.lastname: Kamper
authors.forename: R L
authors.initials: RL
authors.lastname: Lins
authors.forename: P
authors.initials: P
authors.lastname: Zachée
authors.forename: S
authors.initials: S
authors.lastname: Van Bergen
authors.forename: S
authors.initials: S
authors.lastname: Hosten
authors.forename: R
authors.initials: R
authors.lastname: Daelemans
mesh_terms: D004338:Drug Combinations; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D017762:Nadroparin / Q000009:adverse effects* / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006435:Renal Dialysis; D013988:Ticlopidine / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D004338:Drug Combinations; D017762:Nadroparin; D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine